Partial AUC is a key tool in bioequivalence testing for complex generic drugs, helping regulators ensure safe and effective absorption patterns beyond traditional metrics like Cmax and total AUC.
The Hatch-Waxman Amendments of 1984 created the modern generic drug industry by balancing innovation incentives with faster market access. Today, 90% of U.S. prescriptions are generic, saving billions annually.
